Beaumont Health

Metrasens Technology Sees Significant Uptake to Enhance Safety of Hospital Workers from Firearm and Knife Threats

Retrieved on: 
Monday, February 20, 2023
Gun, Health, Hospital, Spectrum Health, Pleasure, Violence, Safety, Incidents, Patient, Safety (gridiron football position), Beaumont Health, Weapon, Bed, Trauma, Security, Nursing

LISLE, Ill., Feb. 20, 2023 /PRNewswire-PRWeb/ -- Metrasens, a leading provider of advanced detection systems for security and safety applications, today announced its progress in enhancing the safety and security of hospitals and healthcare centers throughout the US. Over the last 6 months, adoption of its technology has accelerated, and more than 180 hospitals and healthcare centers are now working with Metrasens to leverage its technology, training expertise, and customer support.    

Key Points: 
  • Over the last 6 months, adoption of its technology has accelerated, and more than 180 hospitals and healthcare centers are now working with Metrasens to leverage its technology, training expertise, and customer support.
  • Customers range from dedicated behavioral health centers to emergency department psychiatric units, rural independent hospitals, academic hospitals, childrens' hospitals, and large multi-site urban health systems.
  • Each has its own individual approach to safety, often extending beyond the front door and protection from guns alone.
  • We are fortunate to have technology that addresses these risks and puts safety first."

Inari Medical Announces First Patient Enrolled in the DEFIANCE Trial, Randomized Controlled Trial Evaluating Clinical Outcomes of the ClotTriever® System in Deep Vein Thrombosis

Retrieved on: 
Thursday, January 12, 2023
MedStar Health, Beaumont Health, RCT, Principal, DVT, VTE, Guy Goodwin, Hospital, MD, Isabella Tree, Patient, Allegheny Health Network, Clinical trial, Interventional radiology, St Thomas' Hospital, Medical device

The first DEFIANCE patient was enrolled by Dr. Abdullah Shaikh, Interventional Radiologist at Allegheny Health Network, Pittsburgh, PA. DEFIANCE will enroll 300 DVT patients at up to 60 centers worldwide.

Key Points: 
  • The first DEFIANCE patient was enrolled by Dr. Abdullah Shaikh, Interventional Radiologist at Allegheny Health Network, Pittsburgh, PA. DEFIANCE will enroll 300 DVT patients at up to 60 centers worldwide.
  • DEFIANCE is Inari’s second RCT, enrolling in parallel to the PEERLESS pulmonary embolism trial.
  • “We’re thrilled to enroll the first patient and officially kick off this important clinical trial,” said Dr. Shaikh.
  • “None of this is possible without the collaboration and dedication of our clinical trial investigators who continually push the field forward in the name of better patient outcomes.”

Tecsys Completes Workday Certified Integration

Retrieved on: 
Monday, January 9, 2023
SCM, Global Alliance for Rabies Control, Software, Partnership, Algorithm, Health, Supply, Spectrum Health, Certification, TSX, Supply chain management, WMS, WDAY, Health care, Hospital, Prisma Health, Beaumont Health, TCS, CSC, Warehouse, Food delivery

MONTREAL, Jan. 9, 2023 /PRNewswire/ -- Tecsys Inc. (TSX: TCS), an industry-leading supply chain management and omnichannel commerce software company and a Workday (NASDAQ: WDAY) Select software partner, today announced that it has achieved Workday Certified Integration status.

Key Points: 
  • MONTREAL, Jan. 9, 2023 /PRNewswire/ -- Tecsys Inc. (TSX: TCS), an industry-leading supply chain management and omnichannel commerce software company and a Workday (NASDAQ: WDAY) Select software partner, today announced that it has achieved Workday Certified Integration status.
  • Tecsys' integration with Workday SCM for Healthcare provides enterprise-wide visibility tailored to healthcare settings.
  • "Tecsys' integration with Workday SCM for Healthcare helps to provide seamless enterprise-wide visibility tailored to the unique dynamics of the healthcare setting," said Jamie O'Halloran , vice president of Global Alliances, Tecsys.
  • More information on Tecsys' integration can be found on the Workday Marketplace , which provides easy access to solutions built by Workday and its software and content partners.

Renowned Breast Surgical Oncologist Joins NYU Langone Health As Director of Women's Health for Suffolk County

Retrieved on: 
Thursday, December 1, 2022
Hospital Insurance and Diagnostic Services Act, SUNY, Trauma center, Trauma, Hospital, Stony Brook University, NYU Langone Health, Ambulatory care, Long Island Community Hospital Amphitheater, Hospital Road, Patient, Beaumont Health, Plainview Hospital, Education, NYU Langone Hospital — Long Island, Icahn School of Medicine at Mount Sinai, Medical Center, South Shore Hospital, MD, NYU, North, Cancer, Health, Research, Melissa, Breast cancer, National Cancer Intelligence Network, Medical imaging

NEW YORK, Dec. 1, 2022 /PRNewswire/ -- Melissa D. Fana, MD , a leading breast surgical oncologist, has joined NYU Langone Health as director of women's health for Suffolk County and chief of service for breast surgery at Long Island Community Hospital , effective December 1.

Key Points: 
  • NEW YORK, Dec. 1, 2022 /PRNewswire/ -- Melissa D. Fana, MD , a leading breast surgical oncologist, has joined NYU Langone Health as director of women's health for Suffolk County and chief of service for breast surgery at Long Island Community Hospital , effective December 1.
  • She sees patients at Perlmutter Cancer Center at NYU Langone Long Island Breast Surgery AssociatesPatchogue, 100 Hospital Road , suite 106.
  • "These attributes will be a tremendous asset as she develops a comprehensive women's health program in Suffolk County over the next several years."
  • She also previously worked at Plainview Hospital, enhancing their breast surgical program, Brookhaven Hospital Memorial Medical Center, and Brookhaven Breast Health Services.

Hani Kador, MD, FACC, is recognized by Continental Who's Who

Retrieved on: 
Tuesday, November 15, 2022
Embolism, Time-invariant system, Ventricular septal defect, ACP, Medicine, Coronary artery disease, Al-Baath University, Echocardiography, Heart, Valvular heart disease, Medical Center, Electrophysiology, MI, Cardiovascular disease, Arrhythmia, Physician, Education, Multimedia, American College of Physicians, Internal medicine, Patient, American College, Heart failure, Beaumont Health, Life, American College of Cardiology, Peripheral artery disease, Infarction, FACC, Continental, Blood, Pharmaceutical industry, Medical imaging, MD, Cardiology

With 14 years of experience in medicine, Dr. Kador is a board-certified, fellowship-trained interventional cardiologist affiliated with Eastside Cardiovascular Medicine in Roseville, MI.

Key Points: 
  • With 14 years of experience in medicine, Dr. Kador is a board-certified, fellowship-trained interventional cardiologist affiliated with Eastside Cardiovascular Medicine in Roseville, MI.
  • As an interventional cardiologist, the doctor sees patients who typically are in life and death situations.
  • He treats patients for cardiovascular disease, peripheral artery disease, arrhythmia, heart attacks, pulmonary embolisms, and blockages.
  • The field includes medical diagnosis and treatment of congenital heart defects, coronary artery disease, heart failure, valvular heart disease, and electrophysiology.

New Study Published in an American Heart Association Journal Indicates that Hello Heart’s Digital Coaching App Could Contribute to Heart Health Equity

Retrieved on: 
Wednesday, September 21, 2022
Cardiology, Telemedicine, Virtual Medicine, General Health, Health, Health Technology, Technology, Apps, Applications, Other Health, Health, Therapy, Profile, Time, Hypertension, Digital therapeutics, Blood pressure, Woman, Risk, MD, Prevalence, Language, Self-management, Health equity, DEI, SBP, Degenerative disease, Beaumont Health, Program, White, CEO, Organization, MBA, CDC, Sex, Infarction, Surgeon, Doctor of Philosophy, Ecosystem, American Heart, Behavior, Black, Heart, Fortune 500, Surgeon General of California, Mortality, AI, Man, Education, Death, Female, Pharmaceutical industry, Medical device, Cardiology, Telemedicine, Virtual Medicine, General Health, Health, Health Technology, Technology, Apps, Applications, Other Health

The study, published as an abstract in the American Heart Associations Hypertension journal, indicates that Hello Hearts hypertension digital coaching program could contribute to health equity, showing similar improvements in heart health for a range of populations, across gender, age, race, and more.

Key Points: 
  • The study, published as an abstract in the American Heart Associations Hypertension journal, indicates that Hello Hearts hypertension digital coaching program could contribute to health equity, showing similar improvements in heart health for a range of populations, across gender, age, race, and more.
  • Closing the gaps in hypertension care is critical to help mitigate the impact of social determinants of health (SDoH) on heart health.
  • The data suggests that Hello Hearts digital coaching tools have the potential to contribute to health equity in hypertension outcomes, especially in women.
  • This important study suggests that digital therapeutics could help level the playing field when it comes to heart health.

Inari Medical Announces Randomized Controlled Trial Evaluating Clinical Outcomes of the ClotTriever® System in Deep Vein Thrombosis

Retrieved on: 
Tuesday, August 30, 2022
Thrombosis, Research, Technology, Post-thrombotic syndrome, Cancer, Swelling, Beaumont Health, NASDAQ, Interventional radiology, Randomized controlled trial, Heart failure, PTS, RCT, Deep vein thrombosis, GLOBE, VTE, Pulmonary embolism, DVT, Publication, FDA, Risk, CE, Trial of the century, Patient, Medical imaging, Medical device

DEFIANCE is a randomized controlled trial (RCT) comparing the clinical outcomes of patients with iliofemoral deep vein thrombosis (DVT) treated with the ClotTriever System versus anticoagulation only.

Key Points: 
  • DEFIANCE is a randomized controlled trial (RCT) comparing the clinical outcomes of patients with iliofemoral deep vein thrombosis (DVT) treated with the ClotTriever System versus anticoagulation only.
  • DEFIANCE is Inaris second RCT and it will run in parallel to the PEERLESS trial.
  • Inari Medical, Inc. is a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases.
  • The ClotTriever system is 510(k)-cleared by FDA and CE marked for the non-surgical removal of clot from peripheral blood vessels, including for the use in the treatment of deep vein thrombosis.

Hello Heart Announces a Groundbreaking Feature for Managing Cholesterol, Becoming the First and Only Digital Therapeutic to Tackle Whole-Heart Health

Retrieved on: 
Tuesday, August 30, 2022
Health, Apps, Applications, Technology, Telemedicine, Virtual Medicine, General Health, Artificial Intelligence, Cardiology, Cardiovascular disease, Mortality, Degenerative disease, Health equity, CEO, Fortune 500, Beaumont Health, Awareness, Pulse, Time, LDL, Infarction, Death, Behavior, Man, Mark (given name), Risk, Habit, Cholesterol, Multimedia, HDL, Medicine, Stroke, Hospital Records, Blood pressure, Population, Cardiac surgery, Hypertension, Therapy, National Cholesterol Education Program, American Heart, Diabetes, Woman, Ecosystem, Health, CDC, AI, Patient, Pharmaceutical industry

Hello Heart , the only digital therapeutic that focuses exclusively on heart health, today announced a new cholesterol management feature, designed to empower people to improve their heart health.

Key Points: 
  • Hello Heart , the only digital therapeutic that focuses exclusively on heart health, today announced a new cholesterol management feature, designed to empower people to improve their heart health.
  • The addition of cholesterol-centric capabilities makes Hello Heart the only solution in the market that looks to manage all key heart health disease factors blood pressure, cholesterol, and diabetes.
  • Hello Heart is the first platform of its kind that is empowering users holistically in all aspects of their heart health.
  • Hello Heart is the only digital therapeutics company to focus exclusively on heart disease, the leading cause of death for U.S. adults.

Oakland University and BHSH System Announce Major Investment to Support Nursing Programs

Retrieved on: 
Thursday, August 18, 2022
Computer science, CEO, OU, College, Oakland University William Beaumont School of Medicine, Honors College (Montana State University), Investment, COVID, School, Hospital, Academic acceleration, Beaumont Health, Jane and Robert Cizik School of Nursing, Compliance, Human services, Health, Patient, COVID-19, Oakland University, NCLEX, Education, BSN, Program, Partnership, Outline of health sciences, Honors colleges and programs, ASD, Nursing school, Spectrum Health, Student, Tradition, Business administration, Trinity College of Arts and Sciences, Spectrum, Physician, Portland State University School of Business Administration, Time, Medicine, Nursing, Music, Engineering

OAKLAND COUNTY, Mich., Aug. 18, 2022 /PRNewswire/ -- To help meet the critical demand for nurses in Michigan, Oakland University and BHSH System announced a new partnership focused on increasing the number of nurses graduating from OU. Through this collaboration, BHSH System will provide Oakland University with financial resources totaling more than $20 million over the next five years for the BHSH Beaumont Health Nurse Scholar program.

Key Points: 
  • Through this collaboration, BHSH System will provide Oakland University with financial resources totaling more than $20 million over the next five years for the BHSH Beaumont Health Nurse Scholar program.
  • Grant recipients will be on a path to become BHSH System team members for at least two years after graduation.
  • "We deeply appreciate BHSH System's partnership and investment into the education of the next generation of health care providers," said Oakland University President Ora Hirsch Pescovitz.
  • Oakland University is a doctoral, Carnegie Classification R2 "High Research Activity" university located in Oakland and Macomb counties, Michigan.

Airspace Link Enables First Real-World Medical Package Delivery Operations In Michigan

Retrieved on: 
Monday, June 27, 2022
Aircraft, View, Movement, Patient, Transport, CEO, UAS, Carbon, Technology, Michigan Economic Development Corporation, Growth, Industry, Beaumont Health, Atmosphere, Health, 2007 Appalachian State vs. Michigan football game, FAA, Environment, Quality of life, Entrepreneurship, VP, State, Beekeeping, Online shopping, Electrification

Armed with a Michigan Mobility Funding Grant from the Michigan Economic Development Corporation's Office of Future Mobility and Electrification, Airspace Link brought together drone operator MissionGO, Beaumont Health, and metropolitan Detroit community leaders to execute Michigan's first real-world package delivery operations via UAS (Uncrewed Aircraft System or "drone").

Key Points: 
  • Armed with a Michigan Mobility Funding Grant from the Michigan Economic Development Corporation's Office of Future Mobility and Electrification, Airspace Link brought together drone operator MissionGO, Beaumont Health, and metropolitan Detroit community leaders to execute Michigan's first real-world package delivery operations via UAS (Uncrewed Aircraft System or "drone").
  • Airspace Link worked with Beaumont Health, a leading health care provider in southeast Michigan, who recognized the opportunity that drones will provide for improving patient health care by moving medical items more efficiently.
  • We are optimistic that drones could help us serve our patients," Melanie Fisher, VP of supply chain operations for Beaumont Health, said.
  • Airspace Link led the project, providing the digital infrastructure and data services required to enable the safe planning and execution of scalable drone delivery and logistics services in Michigan through their proprietary AirHubPlatform.